Piper Sandler Maintains Overweight on Solventum, Raises Price Target to $105

Benzinga · 1d ago
Piper Sandler analyst Jason Bednar maintains Solventum (NYSE:SOLV) with a Overweight and raises the price target from $92 to $105.